Back to Top
Bentracimab Biosimilar - Research Grade
$710.00 - $6,900.00
Bentracimab Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
ticagrelor
Concentration
5mg/ml
Isotype
Fab - G1 - lambda
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Shipping Conditions
Blue ice
Background
Ticagrelor is a reversible P2Y12 antiplatelet agent, and antibodies that bind it are used as research tools to study drug reversal and platelet-aggregation pathways. This product is an unconjugated, non-therapeutic analog of bentracimab, supplied as a human Fab (G1-lambda) recombinant fragment for research use only. It is formulated with low endotoxin to in vivo-suitable standards and manufactured in scalable milligram-to-gram quantities for high-throughput laboratories. Applications include functional and binding assays, drug-neutralization studies, in vitro characterization and preclinical models investigating ticagrelor sequestration, with reliable lot-to-lot reproducibility.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review












